FacebookInstagramTwitterPinterestYouTubeLinkedIn

Takeda’s IBD Treatment ENTYVIO® (vedolizumab) Receives Prestigious Prix Galien Canada Innovative Product Award

Takeda's IBD Treatment ENTYVIO® (vedolizumab) Receives Prestigious Prix Galien Canada Innovative Product Award Oakville, ON - November 23, 2016 -/CNW/ Takeda Canada is pleased to announce that ENTYVIO® (vedolizumab), a gut-selective biologic treatment to treat the two most common types of inflammatory bowel disease (IBD), has been named the 2016 winner of the prestigious Prix Galien [...]

By |2020-10-07T13:36:55-07:00November 29, 2016|News|
Read More

Nova Scotia – Patients First

Nova Scotia - Patients First The GI Society's CEO wrote a letter to the editor at a Halifax newspaper, the Chronicle Herald, about Nova Scotia’s new medication coverage guidelines. We are pleased with Nova Scotia's new patients first policy, which will help make sure patients with inflammatory bowel disease can continue taking medications that work [...]

By |2020-08-10T11:29:16-07:00November 10, 2016|News|
Read More

Diverticular Disease Video

Diverticular Disease Video Watch our diverticular disease video below or click here to watch the video on YouTube. Diverticular Disease Video Transcript Diverticular disease, also known as diverticulosis, is the presence of small sac-like out-pouchings of the colon lining that balloon through the outer colon wall, called diverticula. Diverticulosis can be present without noticeable symptoms, but [...]

By |2020-10-07T13:29:28-07:00November 1, 2016|News|
Read More

GI Society launches new stomach cancer support group

GI Society launches new stomach cancer support group Vancouver, BC – 4 October 2016 – The GI (Gastrointestinal) Society is proud to offer a new support group dedicated exclusively for individuals living with or recovering from stomach (gastric) cancer as well as their loved ones. “A stomach cancer diagnosis often results in emotional stress and [...]

By |2020-08-10T11:30:28-07:00October 4, 2016|News|
Read More

Video: Clostridioides difficile Infection

Video: Clostridioides difficile Infection The human digestive tract is home to an estimated 500 to 1,000 different species of microorganisms, most of which are harmless, or even helpful, and live in harmony. If something upsets the balance, such as treatment with antibiotics or cancer chemotherapy, certain harmful microorganisms can multiply out of control and cause [...]

By |2020-05-20T15:31:50-07:00June 10, 2016|News|
Read More

Video: Biosimilars

Biologics vs. Biosimilars: Is there a difference? Watch our biosimilars video to learn out more. Biologics are very specific, highly effective medicines that improve health outcomes in inflammatory diseases, including Crohn’s disease and ulcerative colitis, which are two types of inflammatory bowel disease (IBD). Biosimilars are products that are similar to an innovator biologic, but [...]

By |2020-04-24T14:11:28-07:00May 31, 2016|News|
Read More

C. difficile Survey (CLOSED)

SURVEY CLOSED C. difficile Survey (CLOSED) The Gastrointestinal Society represents patients with gastrointestinal diseases and disorders on a variety of health care fronts. We have designed this survey to help us understand your opinions and outlook regarding the effects that infection with the C. difficile bacterium has on the lives of patients. We will use [...]

By |2020-08-10T11:32:03-07:00March 8, 2016|News, Surveys|
Read More

Better Pharmacare Coalition Poll Results

Better Pharmacare Coalition poll reveals British Columbians oppose changes to planned expansion to BC government’s Reference Drug Program Better Pharmacare Coalition eager to work with government to get it right for patients Vancouver, February 9, 2016 – A recent Better Pharmacare Coalition (BPC) poll1 has found that British Columbians oppose expansion of the Ministry of [...]

By |2016-02-10T08:07:01-08:00February 9, 2016|News|
Read More

Irritable Bowel Syndrome Survey (CLOSED)

SURVEY CLOSED If you are living in Canada and have irritable bowel syndrome (IBS), or are the parent/caregiver of a child with IBS, please complete this survey on your opinions and experiences of day-to-day life with IBS. If you complete this survey, we will enter you into a draw to win an iPad mini, so [...]

By |2017-02-24T10:41:45-08:00January 15, 2016|News|
Read More

We’re committed to improving the lives of people with gastrointestinal and liver conditions, supporting research, advocating for appropriate patient access to healthcare, and promoting gastrointestinal and liver health.

GI Society Registered Charity 817065352RR0001
CSIR Registered Charity 108090374RR0001

Go to Top